A carregar...
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
BACKGROUND: The RTS,S/AS01 malaria vaccine targets the circumsporozoite protein, inducing antibodies associated with the prevention of Plasmodium falciparum infection. We assessed the association between anti-circumsporozoite antibody titres and the magnitude and duration of vaccine efficacy using d...
Na minha lista:
Publicado no: | Lancet Infect Dis |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Elsevier Science ;, The Lancet Pub. Group
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4655306/ https://ncbi.nlm.nih.gov/pubmed/26342424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00239-X |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|